Anika Therapeutics (ANIK) PT Lifted to $35 at Summer Street Post Q3
Tweet Send to a Friend
Summer Street analyst Mark Landy boosted his price target on Buy-rated Anika Therapeutics (NASDAQ: ANIK) from $28 to $35 following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
